Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2009 Aug;80(4):402-12.
doi: 10.3109/17453670903161124.

18 years of results with cemented primary hip prostheses in the Norwegian Arthroplasty Register: concerns about some newer implants

Affiliations
Comparative Study

18 years of results with cemented primary hip prostheses in the Norwegian Arthroplasty Register: concerns about some newer implants

Birgitte Espehaug et al. Acta Orthop. 2009 Aug.

Abstract

Background and purpose: Few studies have compared the long-term survival of cemented primary total hip arthroplasties (THAs), and several prostheses have been used without adequate knowledge of their endurance. We studied long-term outcome based on data in the Norwegian Arthroplasty Register.

Patients and methods: The 10 most used prosthesis brands in 62,305 primary Palacos or Simplex cemented THAs reported to the Register from 1987 through 2007 were included. Survival analyses with revision as endpoint (for any cause or for aseptic loosening) were performed using Kaplan-Meier and multiple Cox regression with time-dependent covariates. Revision rate ratios (RRs) were estimated for the follow-up intervals: 0-5, 6-10, and > 10 years.

Results: 5 prosthesis brands (cup/stem combinations) (Charnley, Exeter, Titan, Spectron/ITH, Link IP/Lubinus SP; n = 24,728) were investigated with 0-20 year follow-up (inserted 1987-1997). After 18 years, 11% (95% CI: 10.6-12.1) were revised for any cause and 8.4% (7.7-9.1) for aseptic loosening. Beyond 10 years of follow-up, the Charnley cup had a lower revision rate due to aseptic loosening than Exeter (RR = 1.8) and Spectron (RR = 2.4) cups. For stems, beyond 10 years we did not find statistically significant differences comparing Charnley with Titan, ITH, and SP stems, but the Exeter stem had better results (RR = 05). 10 prosthesis brands (9 cups in combination with 6 stems; n = 37,577) were investigated with 0-10 years of follow-up (inserted from 1998 through 2007). The Charnley cup had a lower revision rate due to aseptic loosening than all cups except the IP. Beyond 5 years follow-up, the Reflection All-Poly cup had a 14 times higher revision rate. For stems, beyond 5 years the Spectron-EF (RR = 6.1) and Titan (RR = 5.5) stems had higher revision rates due to aseptic loosening than Charnley. The analyses also showed a marked improvement in Charnley results between the periods 1987-1997 and 1998-2007.

Interpretation: We observed clinically important differences between cemented prosthesis brands and identified inferior results for previously largely undocumented prostheses, including the commonly used prosthesis combination Reflection All-Poly/ Spectron-EF. The results were, however, satisfactory according to international standards.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Description of the study selection procedure. a Palacos cement types: Palacos plain, Palacos with gentamycin, Refobacin – Palacos, Palacos R + G, and Refobacin Bone Cement R, and Simplex cement: Simplex plain, Simplex with erythromycin/ colistin, and Simplex with tobramycin. Same cement brand in acetabulum and femur.
Figure 2.
Figure 2.
Time trends in the use of the 10 most common cemented prosthesis brands in Norway 1989–2007.
Figure 3.
Figure 3.
Time trends in the use of cement brands in Norway 1989–2007.
Figure 4.
Figure 4.
Prosthesis survival with revision of either cup or stem for any cause (a), revision of either cup or stem due to aseptic loosening (b), revision of cup due to aseptic loosening (c), or revision of stem due to aseptic loosening, (d) as endpoint, for 5 cemented prostheses operated 1987–1997 with follow-up through 2007.
Figure 5.
Figure 5.
Prosthesis survival with revision of either cup or stem for any cause (a), revision of either cup or stem due to aseptic loosening (b), revision of cup due to aseptic loosening (c), or revision of stem due to aseptic loosening, (d) as endpoint, for 10 cemented prostheses operated 1998–2007.
Figure 6.
Figure 6.
A graphical representation of the relationship between year of operation (1987–2002) and the log revision rate ratio with aseptic loosening as endpoint for all prostheses (a), Charnley prostheses (b), and all prostheses excluding Charnley (c). The graphs show 95% confidence intervals, together with results of a linear trend test and a test of non-linearity in the effect of year of operation. The graph is calibrated with the log revision rate ratio set to zero at the mean year of operation. The horizontal line shows the reference level.

References

    1. Anthony PP, Gie GA, Howie CR, Ling RS. Localised endosteal bone lysis in relation to the femoral components of cemented total hip arthroplasties. J Bone Joint Surg (Br) 1990;72(6):971–9. - PubMed
    1. Arthursson AJ, Furnes O, Espehaug B, Havelin LI, Soreide JA. Validation of data in the Norwegian Arthroplasty Register and the Norwegian Patient Register: 5,134 primary total hip arthroplasties and revisions operated at a single hospital between 1987 and 2003. Acta Orthop. 2005;76(6):823–8. - PubMed
    1. Black N. Why we need observational studies to evaluate the effectiveness of health care. Bmj. 1996;312(7040):1215–8. - PMC - PubMed
    1. Dall GF, Simpson PM, Breusch SJ. In vitro comparison of Refobacin-Palacos R with Refobacin Bone Cement and Palacos R + G. Acta Orthop. 2007;78(3):404–11. - PubMed
    1. Digas G. New polymer materials in total hip arthroplasty. Evaluation with radiostereometry, bone densitometry, radiography and clinical parameters. Acta Orthop (Suppl 315) 2005;76:3–82. - PubMed

Publication types

LinkOut - more resources